[Catecholamine excretion in patients with eating disorders]
M S Artem'eva1, I A Kovaleva2, B M Kogan3
1Peoples Friendship University of Russia, Moscow.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|November 4, 2015
Summary
This study found that patients with eating disorders exhibit altered catecholamine levels, suggesting a link between dopamine activity and addiction-like symptoms. These findings highlight common pathways in compulsive urges across different conditions.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Context:
- Eating disorders represent complex conditions with significant psychiatric and physiological components.
- Understanding the neurobiological underpinnings of eating disorders is crucial for developing effective treatments.
- Monoamine metabolism, particularly catecholamines, plays a vital role in mood regulation, reward, and impulse control.
Purpose:
- To investigate the relationship between clinical manifestations of eating disorders and the metabolic parameters of key monoamine neurotransmitters.
- To compare the levels of dopamine, noradrenaline, and adrenaline excretion in patients with eating disorders versus a healthy control group.
Summary:
- The study analyzed 21 patients with eating disorders and 26 controls, measuring urinary catecholamine excretion using high-performance liquid chromatography.
- Findings revealed non-specific alterations in catecholamine systems in patients with eating disorders, irrespective of associated stress disorders.
- A significant correlation was observed between dopaminergic activity and the clinical symptoms of addiction in these patients.
Impact:
- Identifies shared pathogenetic mechanisms underlying compulsive urges in various disorders, including eating disorders.
- Suggests that altered dopaminergic activity is a key factor in the development and maintenance of addiction-like symptoms in eating disorders.
- Provides a neurobiological basis for understanding the addictive component of eating disorders, potentially informing novel therapeutic strategies.
Related Concept Videos
01:27Adrenergic Neurons: Neurotransmission
5.8K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.8K
01:27Adrenal Gland Disorders
3.9K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.9K
01:25Adrenergic Agonists: Indirect-Acting Agents
3.0K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
3.0K
01:28Adrenergic Agonists: Mixed-Action Agents
1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
01:28Anorexia Nervosa
1.9K
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.9K